Skip to content Skip to navigation

Efficacy of ruthenium coordination complex-based Rutherrin in a preclinical rat glioblastoma model.

TitleEfficacy of ruthenium coordination complex-based Rutherrin in a preclinical rat glioblastoma model.
Publication TypeJournal Article
Year of Publication2019
AuthorsMunegowda, MAkathatti, Fisher, C, Molehuis, D, Foltz, W, Roufaiel, M, Bassan, J, Nitz, M, Mandel, A, Lilge, L
JournalNeurooncol Adv
Volume1
Issue1
Paginationvdz006
Date Published2019 May-Dec
ISSN2632-2498
Abstract

Background: Glioblastoma is an aggressive brain cancer in adults with a grave prognosis, aggressive radio and chemotherapy provide only a 15 months median survival.Methods: We evaluated the tolerability and efficacy of the Ruthenium-based photosensitizer TLD-1433 with apo-Transferrin (Rutherrin) in the rat glioma 2 (RG-2) model. The specific tumor uptake ratio and photodynamic therapy (PDT) threshold of the rat glioblastoma and normal brain were determined, survival and CD8T-cell infiltration post-therapy were analyzed. Results were compared with those obtained for 5-aminolevulinic acid (ALA)-induced Protoporphyrin IX (PpIX)-mediated photodynamic therapy in the same animal model. As both photosensitizers have different photophysical properties, the number of absorbed photons required to achieve an equal cell kill was determined for in vitro and in vivo studies.Results: A significantly lower absorbed energy was sufficient to achieve LD with Rutherrin versus PpIX-mediated PDT. Rutherrin provides a higher specific uptake ratio (SUR) >20 in tumors versus normal brain, whereas the SUR for ALA-induced PpIX was 10.6. To evaluate the short-term tissue response in vivo, enhanced T2-weighted magnetic resonance imaging (MRI) provided the spatial extent of edema, post PpIX-PDT at twice the cross-section versus Rutherrin-PDT suggesting reduced nonspecific damage, typically associated with a secondary wave of neuronal damage. Following a single therapy, a significant survival increase was observed in rats bearing glioma for PDT mediated by Rutherrin versus PpIX for the selected treatment conditions. Rutherrin-PDT also demonstrated an increased CD8+T-cell infiltration in the tumors.Conclusion: Rutherrin-PDT was well tolerated providing a safe and effective treatment of RG-2 glioma.

DOI10.1093/noajnl/vdz006
Alternate JournalNeurooncol Adv
PubMed ID32642649
PubMed Central IDPMC7212850